Absence of Kaposi's sarcoma-associated herpesvirus (KSHV) in bone marrow cells from Japanese myeloma patients

TO THE EDITOR
Recently, the significance of Kaposi's sarcoma-associated herpesvirus (KSHV) in multiple myeloma (MM) has been discussed since Rettig et al 1 reported that KSHV was detected by polymerase chain reaction (PCR) in bone marrow dendritic cells from 15 of 15 patients with multiple myeloma and from two of eight patients with monoclonal gammopathy of undermined significance (MGUS) but not in that from 10 healthy controls and 16 patients with either hematological malignancies or adenocarcinoma. Their results suggest that KSHV may be involved in the pathogenesis of multiple myeloma. It is hypothesized that KSHV mainly infect stromal cells in myeloma patients and ORF K2, which is a part of KSHV genome, encodes an IL-6-like protein 2 thus mediating growth signal to myeloma cells. In contrast, some other groups in Europe and the United States negated the correlation between the pathogenesis of MM and KSHV infection. [3] [4] [5] However, all of these reports are based on findings in
Figure 1
KSHV DNA amplification by nested PCR from genomic DNA of myeloma patients. The upper panel shows designation of primer sets. PCR using first primer yields a fragment of 620 bp. Then, 1 l out of 25 l of samples from first PCR was used as templates for further PCR using primers for nested PCR. Lower panels show results of nested PCR (primer sets are S1-A1, S1-A2, S2-A1, S2-A2; top to bottom). Length of fragments generated from these primer sets are 434, 516, 474 and 556 bp, respectively. Caucasians and there has been no report regarding the incidence of KSHV infection in Asia. To confirm the presence of KSHV infection in MM patients in Japan, we attempted to detect KSHV DNA in samples from patients with MM by nested-PCR technique.
Bone marrow mononuclear cells (13 cases) and mononuclear cells from pleural effusion (three cases) from patients with MM were examined in this study. Peripheral blood mononuclear cells from patients with plasma cell leukemia (three cases) were also analyzed. In four cases, DNA was extracted from the stromal cell layer obtained from bone marrow cells which had been cultured for 3 or 4 weeks in RPMI 1640 medium containing 10% fetal calf serum under 5% CO 2 with humidified air to obtain stromal cells. Then, adhered cells were removed by treating with trypsin/EDTA solution and DNA was extracted from these cells. Flowcytometry analysis showed that approximately 10-50% of stromal cells expressed ICAM-1 (Immunotech, Marseilles, France) and CD86 (PharMingen, San Diego, CA, USA), which is known to be expressed on dendritic cells, while negative for CD14 (DAKO, Glostrup, Denmark), which is a marker of macrophages, indicating that dendritic cells were contained in the stromal cell layer.
For first PCR reaction 100 ng of genomic DNA was utilized. A primer pair was designed from KSHV genomic DNA sequences (GenBank accession number; U18551) as follows: forward; 5Ј-TGTATTAGCTAACCCTTCTAGCG-3Ј, reverse; 5Ј-TCCGTG TTGTCTACGTCCAG-3Ј. Using this primer pair, a 620 bp DNA fragment that contained the KS330 233 sequence was amplified. We further carried out nested PCR using two sets of primers (Figure 1, upper  panel) .
Primers for nested PCR are as follows: S1; 5Ј-CAGACTCTTCGCTGATGAAC-3Ј, S2; 5Ј-TCATGGCACTCGACAA-GAGT-3Ј, A1; 5Ј-AGATGTGGTACACCAACAGC-3Ј, A2; 5Ј-CCCA-TAAATGACACATTGGTGG-3Ј. This system allowed us to detect KSHV genome from at least 1 pg of genomic DNA from BCBL-1, a Kaposi's sarcoma-derived cell line which is known to be infected by KSHV (kindly supplied by Drs Michael McGrath and Don Ganem through the AIDS Research and Reference Reagent Program, Division of AIDS, NIADA, NIH, Bethesda, MD, USA). A ␤-globin genomic sequence was amplified as an internal control using a primer pair purchased from TaKaRa Biomedicals (Tokyo, Japan).
Results are shown in the lower panel of Figure 1 . In all samples, including all stromal cell samples, no KSHV sequence was detected by nested-PCR, although a clear band was detected in the positive control. The present results indicated no correlation between the occurrence of MM and KSHV infection and did not corroborate the report by Rettig et al.
Rettig et al 6 claimed that heparin contamination in the sample may decrease the sensitivity of PCR. However, since we utilized frozen cells or long-term cultured stromal cells as sources of DNA, heparin contamination should be negligible. Rettig et al 1 also reported that KSHV was found only in stromal cells but not in myeloma cells. However, if stromal cells were infected with KSHV, nested-PCR analysis should be sensitive enough to detect the KSHV genome. Moreover, there was no KSHV DNA detected in purified stromal cells when four cases were examined. Our results suggest that KSHV does not play a significant role in the pathogenesis of MM in the Japanese population.
Philadelphia chromosome-positive cells are equally distributed in AC133
؉ and AC133 ؊ fractions of CD34 ؉ peripheral blood progenitor cells from patients with CML
TO THE EDITOR
Recently, reports of a new surface antigen on primitive human hematopoietic progenitor cells, AC133, were published.
1,2 AC133 has been shown to be selectively expressed on CD34 bright and CD38 − hematopoietic stem and progenitor cells derived from human fetal liver, bone marrow and blood while other more mature blood cells lack expression of this surface antigen.
1,2 Furthermore, a superior potential of CD34 + AC133 + cells compared to CD34 + AC133 − cells in their capacity to engraft NOD/SCID mice has been demonstrated. 3 In malignant hematopoiesis, AC133 is expressed on approximately 60 to 80% of CD34 + cells of patients with acute leukemias. 1,2,4 Highest levels of AC133 expression were detected in samples of myelomonocytic acute leukemias whereas other types of CD34 + AML or ALL showed lower or no expression of AC133. CD34
− leukemias did not reveal any AC133 expression. 1, 2 In addition, AC133 expression could be demonstrated on an AML cell line, MUTZ-2. + HLA-DR − contain large numbers of Ph-negative cells. However, this could not be shown on progenitors expressing Thy-1 or lacking CD38 expression. 6 To investigate whether subpopulations of CD34 + cells co-expressing or lacking the surface marker AC133 contain high amounts of Ph − cells, which could eventually be used for autologous transplantation in CML, we examined subpopulations of PBPC from eight CML patients as well as from three controls, by fluorescence in situ hybridization (FISH) for the presence of the Ph chromosome.
Mononuclear cells (MNC) were prepared from bone marrow or leukapheresis products of eight CML patients and three controls by density gradient centrifugation. For isolation of CD34 + cells we used a MACS CD34 MultiSort Kit (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's instructions. CD34
+ cells were further purified into AC133 + or AC133 − fractions using either another MACS separation column or sorted on a MOFLO flow cytometer equipped with a 480 nm Argon laser (Cytomation, Fort Collins, CO, USA). Cells from bone marrow, leukapheresis products and from selected cell populations were analyzed before and after further selection procedures by interphase FISH for quantitation of Ph + cells as described previously. 7 The relative number of CD34 +
AC133
+ cells is variable between patients with CML. Furthermore, by different selection strategies it was
